2nd Quarter - Report — GILEAD SCIENCES, INC. for GILEAD SCIENCES INC (2015)

Firm

GILEAD SCIENCES, INC.

Client

GILEAD SCIENCES INC

Income

—

Expenses

$550,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

10 issue areas, each in the filer's own words, with who lobbied on it and where.

Foreign Relations FOR

Issues related to access to pharmaceuticals, international finance for health services and intellectual property protection.

Lobbyist	Covered position, as disclosed
ARANTHAN STEVE JONES, II	—

Contacted: State, Dept of (DOS); Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES; Veterans Affairs, Dept of (VA); Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); Executive Office of the President (EOP); SENATE

Budget/Appropriations BUD

Issues related to healthcare funding and cost-savings.

Lobbyist	Covered position, as disclosed
ARANTHAN STEVE JONES, II	—

Contacted: Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES; Veterans Affairs, Dept of (VA); Commerce, Dept of (DOC); State, Dept of (DOS); SENATE

Defense DEF

Education related to HCV issues.

Lobbyist	Covered position, as disclosed
JOSEPH GROGAN	—
ARANTHAN STEVE JONES, II	—
DAVID PULLIAM	—

Contacted: SENATE; Veterans Affairs, Dept of (VA); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); Defense, Dept of (DOD); State, Dept of (DOS)

Copyright/Patent/Trademark CPT

Specific lobbying issues: HIV/AIDS testing and treatment, technology transfer and patent rights and funding, patent reform legislation. Patient Protection and Affordable Care Act implementation.Issues related to access to pharmaceuticals and intellectual property protection.

Lobbyist	Covered position, as disclosed
JOSEPH GROGAN	—
ARANTHAN STEVE JONES, II New	Health Policy Advisor, Senior Health Policy Advisor, Health Policy Director, Deputy Chief of Staff & Senior Advisor, Chief if Staff, Chieft of Staff and Senior Policy Advisor, Director Policy and Researvch, Policy Director, House of Representatives.
DAVID PULLIAM	—

Contacted: Commerce, Dept of (DOC); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; State, Dept of (DOS); SENATE; Health & Human Services, Dept of (HHS); Veterans Affairs, Dept of (VA); Defense, Dept of (DOD)

Health Issues HCR

Pending healthcare legislation and potential impact on the biopharmaceutical industry; Ryan White Care Act reauthorization; Hepatitis C policy; PEPFAR reauthorization, Ryan White Care Act reauthorization; Hepatitis C (HCV) policy; PEPFAR reauthorization; HIV/AIDS research, testing, and treatment; Affordable Care Act implementation; HCV screening and linkage to care programs; House Committee on Energy and Commerce 21st Century Cures initiative. HIV/AIDS testing and treatment, technology transfer and patent rights, and funding. Patient Protection and Affordable Care Act implementation. Hepatitis funding for screening and linkage to care programs.

Lobbyist	Covered position, as disclosed
JOSEPH GROGAN	—
ARANTHAN STEVE JONES, II New	Health Policy Advisor, Senior Health Policy Advisor, Health Policy Director, Deputy Chief of Staff & Senior Advisor, Chief if Staff, Chieft of Staff and Senior Policy Advisor, Director Policy and Researvch, Policy Director, House of Representatives.
DAVID PULLIAM	—

Contacted: State, Dept of (DOS); Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); Executive Office of the President (EOP); SENATE; Veterans Affairs, Dept of (VA); Health & Human Services, Dept of (HHS)

Veterans VET

Appropriations; education related to Hepatitis C. Access to Care Act, HR 4810. Issues related to coverage, access and reimbursement of pharmaceuticals for veterans.

Lobbyist	Covered position, as disclosed
JOSEPH GROGAN	—
ARANTHAN STEVE JONES, II	—
DAVID PULLIAM	—

Contacted: State, Dept of (DOS); Veterans Affairs, Dept of (VA); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); SENATE; Defense, Dept of (DOD); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS)

Bills named: H.R. 4810 (114th)

Medicare/Medicaid MMM

Ryan White Care Act reauthorization; Hepatitis C (HCV) policy; PEPFAR reauthorization; HIV/AIDS research, testing, and treatment; Affordable Care Act implementation; HCV screening and linkage to care programs; House Committee on Energy and Commerce 21st Century Cures initiative. Federal program coverage; access and reimbursement issues for Hepatitis C, HIV, and oncology products. Viral Hepatitis Testing, Screening and treatment;HIV Testing, Research and Treatment; Coverage of pharmaceuticals, cost-sharing and other access issues; 21st Century Cures initiative; Implementation of Public Law No: 111-148, the Patient Protection and Affordable Care Act;Issues related to coverage and reimbursement of pharmaceuticals; and FDA issues and 340B.

Lobbyist	Covered position, as disclosed
JOSEPH GROGAN	—
ARANTHAN STEVE JONES, II New	Health Policy Advisor, Senior Health Policy Advisor, Health Policy Director, Deputy Chief of Staff & Senior Advisor, Chief if Staff, Chieft of Staff and Senior Policy Advisor, Director Policy and Researvch, Policy Director, House of Representatives.
DAVID PULLIAM	—

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Defense, Dept of (DOD); Veterans Affairs, Dept of (VA); State, Dept of (DOS); Commerce, Dept of (DOC)

Pharmacy PHA

Coverage of pharmaceuticals, cost-sharing and other access issues; 21st Century Cures initiative; Implementation of Public Law No: 111-148, the Patient Protection and Affordable Care Act; Issues related to coverage and reimbursement of pharmaceuticals; Issues related to Medicare, Medicaid and Affordable Care Act implementation; and FDA issues and 340B.

Lobbyist	Covered position, as disclosed
ARANTHAN STEVE JONES, II	—

Contacted: HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Commerce, Dept of (DOC); Defense, Dept of (DOD); State, Dept of (DOS); Health & Human Services, Dept of (HHS); Veterans Affairs, Dept of (VA); SENATE

Science/Technology SCI

Issues related to pharmaceutical innovation and intellectual property protection.

Lobbyist	Covered position, as disclosed
ARANTHAN STEVE JONES, II	—

Contacted: SENATE; Defense, Dept of (DOD); State, Dept of (DOS); Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; Veterans Affairs, Dept of (VA)

Trade (domestic/foreign) TRD

International Trade and protection of intellectual property; HIV policy Issues, HCV issues, Patent Reform.

Lobbyist	Covered position, as disclosed
JOSEPH GROGAN	—
DAVID PULLIAM	—

Contacted: Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); Veterans Affairs, Dept of (VA); HOUSE OF REPRESENTATIVES; State, Dept of (DOS); Defense, Dept of (DOD); Executive Office of the President (EOP); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.